彭康詠 Kang-Yung Peng, 臺大醫院

Name:  Peng, Kang-Yung 彭康詠

A. Education

Ph.D.      October 2010        Institute of Biopharmaceutical Science, School of Pharmaceutical Science,

National Yang-Ming University, Taiwan

M.S.        June 2004       Institute of Biopharmaceutical Science, School of Life Science, National

Yang-Ming University, Taiwan

B.S. June 2001       School of Pharmacy undergraduate program, China Medical University, Taiwan

B. Research/Employment History

Dec. 2011-Sep. 2012    Postdoctoral Researcher, Research Center for Drug Discovery, National Yang-Ming University, Taiwan

Oct. 2012-Present       Postdoctoral Researcher, Department of Internal medicine, College of Medicine, National Taiwan University, Taiwan

C. Awards

2001                 Presidential Award, School of Pharmacy, China Medical University, Taiwan

2010            Prize for the excellent paper, National Yang-Ming University, Taiwan

2014                              Young Investigator Award of 10th Asian Pacific Congress of Hypertension

D. Publication

1. Guang-Huar Young, Tao-Min Huang, Che-Hsiung Wu, Chun-Fu Lai, ChunCheng Hou, Kang-Yung   Peng, Chan-Jung Liang, Shuei-Liong Lin, Shih-Chung Chang, Pi-Ru Tsai, Kwan-Dun Wu, Vin-Cent Wu, and Wen-Je Ko, and the NSARF group. (2014). Hemojuvelin Modulates Iron Stress During Acute Kidney Injury: Improved by Furin Inhibitor. Antioxidants & Redox Signaling, 20(8),1181-94. (SCI, 9/124, ENDOCRINOLOGY & METABOLISM).

2. Pei-Lun Hsu, Lin-Yea Horng, Kang-Yung Peng, Chia-Ling Wu, Hui-Chig Sung, Rong-Tsun Wu (2013). Activation of mitochondrial function and haemoglobin expression in nonhaematopoietic cells by an EPO-inducer ameliorates ischemic diseases in mice. . British Journal of Pharmacology, 169(7):1461-76. (SCI, 21/256, PHARMACOLOGY & PHARMACY).

3. Kang-Yung Peng, Lin-Yea Horng, Hui-Ching Sung, Hui-Chuan Huang, Rong-Tsun Wu* (2011). Antiosteoporotic activity of Dioscorea alata L. cv. Phyto through driving mesenchymal stem cells differentiation for bone formation.. Evidence-Based Complementary and Alternative Medicine, 2011:712892.. (SCI, 1/22, INTEGRATIVE & COMPLEMENTARY MEDICINE).

4. Kang-Yung Peng, Lin-Yea Horng, Hui-Ching Sung, Rong-Tsun Wu* (2011). Hepatocyte growth factor has a role in the amelioration of diabetic vascular complications via autophagic clearance of advanced glycation end products: Dispo85E, an HGF inducer, as a potential botanical drug. Metabolism, 60(6):888-92. (SCI, 57/122, ENDOCRINOLOGY & METABOLISM).